Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CHFLF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CHFLF and 80,000+ other tickers.
See exactly how CHFLF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CHFLF and 80,000+ other tickers.
China Feihe Limited operates as an investment holding firm, primarily engaged in the production and sale of infant milk formula across Mainland China and the United States. Its broader product portfolio also encompasses raw milk, a variety of adult milk powders, liquid milk products, and healthcare items, alongside specialized soybean and goat milk powders. Additionally, the company is involved in the retail distribution of vitamins, minerals, herbs, and other nutritional supplements. Products are distributed through a multi-faceted sales network, including traditional distributors, major…
